Manning & Napier Group, LLC Royalty Pharma PLC Transaction History

Manning & Napier Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$32.77 - $39.4 $6,324 - $7,604	-193 Reduced 0.14%	137,007 $4.94 Million
Q4 2022 Jan 26, 2023	SELL	$39.17 - $44.04 $26,674 - $29,991	-681 Reduced 0.49%	137,200 $0
Q3 2022 Oct 18, 2022	SELL	$39.88 - $44.65 $193,178 - $216,284	-4,844 Reduced 3.39%	137,881 $5.54 Million
Q2 2022 Jul 12, 2022	BUY	$37.53 - $44.22 $5.36 Million - $6.31 Million	142,725 New	142,725 $6 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Manning & Napier Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Manning & Napier Group, LLC with notifications on news.